An Observational Study of Mycophenolate Mofetil Combined With Glucocorticoid in the Treatment of Relapse Vogt-Koyanagi-Harada Disease
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
This project is designed to test the hypothesis that Mycophenolate Mofetil is clinically useful for patients with relapse Vogt-Koyanagi-Harada disease
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:
• Subject is 18 to 70 years of age.
• Subjects who do not have previous, active or latent tuberculosis (TB).
• Subject must start Vogt-Koyanagi-Harada disease more than two months, and develop at least one recurrence.
Locations
Other Locations
China
xiaomin Zhang
RECRUITING
Tianjin
Contact Information
Primary
xiaomin Zhang
xiaomzh@126.com
+8613920023990
Time Frame
Start Date: 2021-10-01
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 15
Treatments
Mycophenolate Mofetil therapy Group
An initial dose of 0.5-1.0g bid MMF was orally administered every day, glucocorticoid was started at a dose of 0.5-0.8 mg/kg/day and no more than 60 mg/day.
traditional therapy group
Patients were treated with glucocorticoids alone or glucocorticoids combined with Cyclosporine.
Related Therapeutic Areas
Sponsors
Leads: Tianjin Medical University